The novel treatment of tirzepatide peptide represents a significant development in the handling of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets dual pathways – the GLP-1 hormone and GIP https://tirzepatide-peptide125919.fare-blog.com/42425084/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment